BETA
BETA
Edwards Lifesciences
EW76
$62.37arrow_drop_up4.47%$2.67
S&P500
EW76
$62.37
arrow_drop_up4.47%| Key Stats | |
|---|---|
| Open | $61.31 |
| Prev. Close | $59.70 |
| EPS | 2.32 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 60.28 | 61.80 |
| 52 Week Range | 58.93 | 96.12 |
| Ratios | |
|---|---|
| EPS | 2.32 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.85% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
EWarrow_drop_up0.80%
US Healthcare Sectorarrow_drop_up0.50%
US Marketarrow_drop_down1.27%
check_circle
EW / Market
EW exceeded the US Market which returned -1.27% over the last twenty four hours.check_circle
EW / Healthcare Sector
EW exceeded the US Healthcare sector which returned 0.50% over the last twenty four hours.Edwards Lifesciences (EW) Statistics
Keep an eye on Edwards Lifesciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Edwards Lifesciences (EW) stock's performance compared to its sector and the market over the past year?
Over the past year, Edwards Lifesciences (EW) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.05%, Edwards Lifesciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 51.99%, it has fallen short of the market average. This comparison highlights Edwards Lifesciences's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Edwards Lifesciences (EW) stock?
The PE (Price to Earnings) ratio of Edwards Lifesciences (EW) is currently 38.03. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Edwards Lifesciences (EW) stock?
The Earnings Per Share (EPS) for Edwards Lifesciences (EW), calculated on a diluted basis, is $1.64. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Edwards Lifesciences (EW) stock?
The operating margin for Edwards Lifesciences (EW) is 26.63%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Edwards Lifesciences (EW) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Edwards Lifesciences (EW) is $1.96B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Edwards Lifesciences (EW) have?
Edwards Lifesciences (EW) has a total debt of $693M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$525.4M.
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.